ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Geriatric Medicine

Top Geriatric Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSHUA SHUA-HAIM M.D

Geriatric Medicine

26,190

$2.21M

712
653 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $67

MARK PASS MD

Geriatric Medicine

25,679

$2.03M

806
784 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$79
Average prescription price

Avg: $67

AHMED MIRZA M.D.

Geriatric Medicine

22,516

$1.14M

624
603 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$51
Average prescription price

Avg: $67

ROBERT PLATZMAN D.O.

Geriatric Medicine

17,924

$963K

494
471 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $67

MICHELLE REISNER MD

Geriatric Medicine

17,408

$1.18M

776
693 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$68
Average prescription price

Avg: $67

GREGORIO GUILLEN M.D

Geriatric Medicine

17,023

$1.32M

630
473 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $67

ANUSUYA JEYAKUMAR MD

Geriatric Medicine

15,859

$1.06M

522
385 are 65+

19%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $67

KATHERINA CANALES M.D.

Geriatric Medicine

15,601

$1.25M

481
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 29%

$80
Average prescription price

Avg: $67

SUHAS PATEL M.D

Geriatric Medicine

15,537

$983K

616
586 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $67

KARTIKEY NANAVATI MD

Geriatric Medicine

15,359

$841K

509
487 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $67

KARAMBIR DALAL M.D.

Geriatric Medicine

13,901

$1.04M

767
701 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$75
Average prescription price

Avg: $67

ROWEN DIANO MD

Geriatric Medicine

13,758

$912K

400
361 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $67

NICHOLAS GUITTARI M. D.

Geriatric Medicine

13,602

$836K

316
275 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $67

PRADIP SHAH M.D.

Geriatric Medicine

13,162

$841K

428
402 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $67

AHSAN ABDULGHANI MD

Geriatric Medicine

12,710

$777K

503
309 are 65+

21%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $67

MUTHU ARUNACHALAM M.D.,

Geriatric Medicine

12,423

$637K

362
346 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$51
Average prescription price

Avg: $67

MICHAEL GOLDIS D.O.

Geriatric Medicine

12,159

$765K

535
430 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $67

EMILY BAHLER DO

Geriatric Medicine

11,096

$770K

341
336 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $67

ANNE-MARIE GRACIA M.D., MPH

Geriatric Medicine

10,617

$587K

408
368 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $67

YONG SHI MD

Geriatric Medicine

10,552

$654K

276
241 are 65+

19%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $67

TERRI KATZ M.D

Geriatric Medicine

10,124

$624K

383
372 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $67

ARTHUR SHEPPELL MD

Geriatric Medicine

9,490

$538K

540
499 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $67

RICHARD BULLOCK MD

Geriatric Medicine

8,616

$749K

467
430 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$87
Average prescription price

Avg: $67

KARIM KHIMANI MD

Geriatric Medicine

8,444

$706K

371
338 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $67

HARRY CHAIKIN MD

Geriatric Medicine

8,345

$556K

294
283 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank